‘I think it’s a mistake by Europe’ – Argentinian President Fernandez on Sputnik V approval delay
RT published this video item, entitled …
Gam-COVID-Vac, trade-named Sputnik V, is a COVID-19 vaccine developed by the Gamaleya Research Institute of Epidemiology and Microbiology, and registered on 11 August 2020 by the Russian Ministry of Health. It has been approved for distribution in Russia.
The phase III trial for Gam-COVID-Vac was registered on 28 August 2020, and is a randomised, double-blind, placebo-controlled, multi-centre clinical trial involving 40,000 volunteers. The phase III trial is scheduled to run until May 2021.
On 5 December 2020, Russia began mass vaccinations in Moscow, with 70 clinics inoculating those most at risk from the virus. Health workers and teachers were said to have priority in the first mass immunisation programme. People who had received injections in the last 30 days or had respiratory diseases in the previous two weeks were excluded, as well as those with certain chronic illnesses, and pregnant and breastfeeding women.
RT published this video item, entitled …
FRANCE 24 English published this video …
CGTN published this video item, entitled …
CGTN published this video item, entitled …
FRANCE 24 English published this video …
Al Jazeera English published this video …
DW News published this video item, …
DW News published this video item, …
RT published this video item, entitled …
Global News published this video item, …
Global News published this video item, …
RT published this video item, entitled …
RT published this video item, entitled …
RT published this video item, entitled …